|
|
A Suwa, M Hirakata, Y Takeda, Y Okano, T Mimori, S Inada, F Watanabe, H Teraoka, W S Dynan, J A Hardin
J Clin Invest. 1996;
97(6):1417
doi:10.1172/JCI118562
Abstract |
Full text
| PDF

D
NA-dependent protein kinase (DNA-PK) is an important nuclear enzyme which consists of a catalytic subunit known as DNA-PKcs and a regulatory component identified as the Ku autoantigen. In the present study, we surveyed 312 patients in a search for this specificity. 10 sera immunoprecipitated a large polypeptide which exactly comigrated with DNA-PKcs in SDS-PAGE. Immunoblot analysis demonstrated that this polypeptide was recognizable by a rabbit antiserum specific for DNA-PKcs. Although the patient sera did not bind to biochemically purified DNA-PKcs in immunoblots or ELISA, they were able to deplete DNA-PK catalytic activity from extracts of HeLa cells in a dose-dependent manner. We conclude that these antibodies should be useful probes for studies which aim to define the role of DNA-PK in cells. Since six sera simultaneously contained antibodies to the Ku protein, these studies suggest that relatively intact forms of DNA-PK complex act as autoantigenic particles in selected patients.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(14)
| Title and authors |
Publication |
Year |
Anti-Ku antibodies: Clinical, genetic and diagnostic insights
C. Belizna, D. Henrion, A. Beucher, C. Lavigne, A. Ghaali, H. Lévesque
|
Autoimmunity Reviews
|
2010 |
Advances in understanding newer autoantibodies and their role as biomarkers in systemic lupus erythematosus
Marvin J Fritzler
|
Expert Opin. Med. Diagn.
|
2007 |
Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions
Michito HIRAKATA
|
Jpn. J. Clin. Immunol.
|
2007 |
Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs
Indira Neeli, Mekel M. Richardson, Salar N. Khan, Danielle Nicolo, Marc Monestier, Marko Z. Radic
|
Molecular Immunology
|
2007 |
Autoantigenicity of nucleolar complexes
Tim J.M Welting, Reinout Raijmakers, Ger J.M Pruijn
|
Autoimmunity Reviews
|
2003 |
Enhanced DNA damage-induced p53 peptide phosphorylation and cell-cycle arrest in Sjogren's syndrome cells
G. Henriksson, M. Brant, A. Sallmyr, S. Fukushima, R. Manthorpe, A. Bredberg
|
Eur J Clin Invest
|
2002 |
Wiley Encyclopedia of Molecular Medicine
William S. Dynan, John A. Hardin
|
Wiley Encyclopedia of Molecular Medicine
|
2002 |
The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen
Livia A. Casciola-Rosen, Ann F. Pluta, Paul H. Plotz, Amy E. Cox, Steven Morris, Fredrick M. Wigley, Michelle Petri, Allan C. Gelber, Antony Rosen
|
Arthritis Rheum
|
2001 |
A method to detect particle-specific antibodies against Ku and the DNA-dependent protein kinase catalytic subunit in autoimmune sera
Farahdiba Jafri, John A. Hardin, William S. Dynan
|
Journal of Immunological Methods
|
2001 |
Abnormal DNA Damage-inducible Protein in Cells from Sjögren's Syndrome Patients
Shahram Lavasani, Gunnel Henriksson, Marta Brant, Agnethe Henriksson, Marina Radulic, Rolf Manthorpe, Anders Bredberg
|
Journal of Autoimmunity
|
1998 |
|